BIO

Bio-rad Laboratories-a

-$5.5B

Net Activity

Institutions Holding

21

Popularity Rank

#1469

Avg Weight

0.01%

Total Value

$72.3M

Ownership Trend

21 institutions currently hold BIO, with 4 net buyers and 9 net sellers this quarter.

Institutional Moves

Institutional Moves (Q2 2026)

Majority Decreased

Based on recent trading activity

Net Selling Institutions

9

Net Buying Institutions

4

Key Holders

Key Holders

Top 5 by Value

AA
Assenagon Asset Management S.A.
$68.5M
HF
Handelsbanken Fonder AB
$1.9M
FC
First Citizens Bank & Trust Co
$675.3K
PF
Patriot Financial Group Insurance Agency, LLC
$391.4K
GI
GAMMA Investing LLC
$325.3K

Top 5 by Conviction

AA
Assenagon Asset Management S.A.
0.09%
PF
Patriot Financial Group Insurance Agency, LLC
0.04%
IW
Insight Wealth Strategies, LLC
0.02%
HF
Handelsbanken Fonder AB
0.01%
FC
First Citizens Bank & Trust Co
0.01%
View all 21 holding institutions

Quarterly Activity

Recent Activity

+$69.2M

Total Buy Value

$1.8M

Total Sell Value

New buy1
Trim7
Add3
Sold out2

4

Net Buyers

9

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding BIO-RAD LABORATORIES-A (BIO)?
Major stakeholders currently include Assenagon Asset Management S.A. ($68.5M), Handelsbanken Fonder AB ($1.9M), First Citizens Bank & Trust Co ($675.3K). Based on the latest 13F filings, there are a total of 21 tracked investment funds and institutions maintaining positions in BIO.
What is the overall institutional sentiment toward BIO recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $5.5B, driven by 4 managers accumulating shares while 9 reduced their exposure.
Which institutions have been selling or reducing their BIO positions?
In the latest period, 7 funds trimmed their holdings, and 2 managers completely exited their positions. The aggregate reported sell value was $1.8M.
Are there any notable investors adding BIO to their portfolios?
Yes, buying activity remains notable. 1 institutions opened new positions in {ticker}, and 3 existing holders added to their shares. The total reported buy value for the quarter amounted to $69.2M.

Related Stocks

Same Sector

Other stocks in the same GICS sector

JNJ

Johnson & Johnson

Institutions Holding

468

Total reported value

$6.2B

20 institutions currently hold both BIO and this stock

View detail
LLY

Eli Lilly & Co

Institutions Holding

446

Total reported value

$8.3B

20 institutions currently hold both BIO and this stock

View detail
ABBV

Abbvie INC

Institutions Holding

419

Total reported value

$3.2B

20 institutions currently hold both BIO and this stock

View detail

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

601

Total reported value

$20.1B

310 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

563

Total reported value

$25.2B

299 13F institutions increased their position this quarter

View detail
VUG

Vanguard Growth ETF

Institutions Holding

302

Total reported value

$4.3B

269 13F institutions increased their position this quarter

View detail